ASH 2023: Cell Therapy Abstract Highlights
The 2023 ASH Annual Meeting brought together a wealth of groundbreaking research and advancements in the realm of Cell Therapy. With a total of 187 abstracts, the event mirrored the previous year’s engagement, showcasing a sustained interest and commitment to the field. This year’s abstracts, comprising 83% clinical data presentations, provided a comprehensive overview of trial results, pooled analyses, and trial outlines.
You May Also Be Interested In…
Learn More About Cell Therapy
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
